Article
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.
Journal of the American College of Cardiology - 6 Sept 2016
Favalli Valentina, Disabella Eliana, Molinaro Mariadelfina, Tagliani Marilena, Scarabotto Anna, Serio Alessandra, Grasso Maurizia, Narula Nupoor, Giorgianni Carmela, Caspani Clelia, Concardi Monica, Agozzino Manuela, Giordano Calogero, Smirnova Alexandra, Kodama Takahide, Giuliani Lorenzo, Antoniazzi Elena, Borroni Riccardo G, Vassallo Camilla, Mangione Filippo, Scelsi Laura, Ghio Stefano, Pellegrini Carlo, Zedde Marialuisa, Fancellu Laura, Sechi GianPietro, Ganau Antonello, Piga Stefania, Colucci Annarita, Concolino Daniela, Di Mascio Maria Teresa, Toni Danilo, Diomedi Marina, Rapezzi Claudio, Biagini Elena, Marini Massimiliano, Rasura Maurizia, Melis Maurizio, Nucera Antonia, Guidetti Donata, Mancuso Michelangelo, Scoditti Umberto, Cassini Pamela, Narula Jagat, Tavazzi Luigi, Arbustini Eloisa
Abstract excerpt
BACKGROUND: Anderson-Fabry disease (AFD) is a rare X-linked lysosomal storage disease, caused by defects of the alpha-galactosidase A (GLA) gene. AFD can affect the heart, brain, kidney, eye, skin, peripheral nerves, and gastrointestinal tract. Cardiology (hypertrophic cardiomyopathy), neurology (cryptogenic stroke), and nephrology (end-stage renal failure) screening studies suggest the prevalence of GLA variants...
Topics
- Adolescent
- Adult
- Child
- Fabry Disease
- Female
- Genetic Testing
